| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.04 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |